Estados financieros detallados de Quantum BioPharma Ltd. (QNTM): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | $20630 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | 0 | $182612 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | $20630 | -$182612 | -$2.6M | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | 0 | 0 | 0 | 0 | $7.8M | $6.3M | $6.9M | $3.9M | $6.1M | $2.8M |
| Generales y Administrativos | $29628 | $2.8M | $17.5M | $20.5M | $18.1M | $23.4M | $16.0M | $13.2M | $9.3M | $12.0M |
| Gastos Operativos | $177984 | $2.8M | $18.6M | $30.0M | $30.7M | $33.7M | $27.4M | $23.8M | $16.1M | $15.3M |
| Beneficio Operativo | 0 | -$2.8M | 0 | -$30.6M | -$30.7M | -$33.7M | -$27.4M | -$23.8M | -$16.1M | -$15.3M |
| EBITDA | -$29628 | -$2.8M | -$16.5M | -$32.0M | -$24.3M | -$29.8M | -$22.1M | -$15.7M | -$14.4M | -$25.8M |
| Gastos por Intereses | 0 | 0 | 0 | $155316 | $235581 | $69404 | $48822 | $299 | $47577 | $618640 |
| Beneficio Antes de Impuestos | -$29628 | -$2.8M | -$16.7M | -$46.5M | -$28.5M | -$33.9M | -$26.7M | -$18.2M | -$14.9M | -$27.0M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$29628 | -$2.8M | -$22.6M | -$39.1M | -$31.8M | -$35.3M | -$23.6M | -$17.9M | -$14.2M | -$26.2M |
| BPA | $-0.29 | $-27.75 | $-183.54 | $-360.45 | $-171.62 | $-65.63 | $-39.62 | $-29.39 | $-12.49 | $-8.11 |
| BPA Diluido | $-0.29 | $-27.75 | $-183.54 | $-360.45 | $-171.62 | $-65.63 | $-39.62 | $-29.39 | $-12.49 | $-8.11 |
| Acciones en Circulación (Diluidas) | $101000 | $101000 | $90848 | $108557 | $185291 | $537618 | $595882 | $609056 | $1.1M | $3.3M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $7137 | $3.8M | $15.5M | $6.0M | $17.5M | $35.3M | $17.0M | $2.8M | $6.0M | $1.9M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | $158036 | $23188 | $756100 | $1.2M | $4.3M |
| Cuentas por Cobrar | 0 | $234201 | $979547 | $1.6M | $161342 | $500964 | $374377 | $7.4M | $3.8M | $230632 |
| Inventario | 0 | 0 | 0 | $709373 | 0 | 0 | 0 | 0 | $117242 | $52038 |
| Activos Corrientes | $7137 | $4.3M | $16.6M | $8.6M | $26.9M | $45.9M | $17.9M | $11.1M | $12.1M | $6.5M |
| Inmovilizado Material | 0 | $6.6M | $8.9M | $9.0M | 0 | $168307 | $260925 | $120421 | $130382 | $169040 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | $16.8M | $13.4M | $16.2M | $12.0M | $5.4M | $4.9M | $4.5M |
| Activos Totales | $7137 | $10.9M | $38.7M | $43.2M | $42.0M | $63.0M | $38.4M | $17.5M | $17.1M | $11.1M |
| Cuentas por Pagar | $28309 | $1.0M | $1.3M | $3.4M | $2.1M | $3.0M | $2.8M | $3.2M | $3.3M | 0 |
| Deuda a Corto | 0 | 0 | 0 | $1.4M | $384647 | $300549 | $300549 | $300549 | $771142 | $1.9M |
| Pasivos Corrientes | $61434 | $1.0M | $1.3M | $6.8M | $5.6M | $8.7M | $7.8M | $4.6M | $6.7M | $6.0M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $61434 | $1.0M | $1.3M | $6.9M | $5.7M | $8.8M | $7.9M | $4.6M | $6.7M | $6.0M |
| Reservas | -$1.3M | -$3.3M | -$19.5M | -$59.1M | -$90.9M | -$126.2M | -$144.2M | -$157.9M | -$172.1M | -$197.9M |
| Patrimonio Neto | -$54297 | $9.9M | $37.5M | $36.3M | $36.3M | $54.1M | $30.5M | $13.2M | $11.5M | $6.9M |
| Deuda Total | 0 | 0 | 0 | $1.6M | $510609 | $555905 | $516423 | $339199 | $824922 | $1.9M |
| Deuda Neta | -$7137 | -$3.8M | -$15.5M | -$4.4M | -$17.0M | -$34.9M | -$16.5M | -$3.2M | -$6.4M | -$4.3M |
| Capital Circulante | -$54297 | $3.3M | $15.3M | $1.7M | $21.3M | $37.2M | $10.0M | $6.5M | $5.4M | $419295 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$29628 | -$2.8M | -$16.7M | -$34.1M | -$28.5M | -$33.9M | -$26.7M | -$18.2M | -$14.9M | -$26.2M |
| Amortizaciones | 0 | 0 | $134129 | $1.9M | $3.9M | $4.0M | $4.5M | $2.5M | $490571 | $555334 |
| Compensación en Acciones | 0 | $2.4M | $4.7M | $12.1M | $8.1M | $7.4M | $1.5M | $3.8M | $152214 | $2.9M |
| Cambio en Capital Circulante | $2390 | $305407 | -$242373 | $1.1M | $807136 | $2.9M | -$7.1M | $1.6M | $9.8M | $2.0M |
| Flujo de Caja Operativo | -$27238 | -$119176 | -$13.6M | -$13.7M | -$19.1M | -$20.7M | -$28.3M | -$10.8M | -$6.9M | -$8.4M |
| Inversiones (CapEx) | 0 | -$6.1M | -$3.0M | -$293126 | 0 | -$500000 | -$363958 | 0 | 0 | 0 |
| Adquisiciones | 0 | 0 | $1.5M | $1752 | 0 | $768964 | 0 | $31783 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | -$1.9M | -$3.0M | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$27238 | -$6.2M | -$16.5M | -$14.0M | -$19.1M | -$21.2M | -$28.7M | -$10.8M | -$6.9M | -$8.4M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | -100.0% | | | | | | | |
| Crecimiento Beneficio Neto (anual) | | -9360.0% | -707.7% | -72.8% | +18.7% | -11.0% | +33.1% | +24.2% | +20.7% | -84.3% |
| Crecimiento BPA (anual) | | -9469.0% | -561.4% | -96.4% | +52.4% | +61.8% | +39.6% | +25.8% | +57.5% | +35.1% |
| Cambio en Acciones (anual) | | +0.0% | -10.1% | +19.5% | +70.7% | +190.1% | +10.8% | +2.2% | +86.7% | +189.0% |
| Crecimiento FCF (anual) | | -22682.3% | -166.5% | +15.3% | -36.6% | -11.1% | -35.1% | +62.3% | +36.5% | -21.9% |
| Margen Bruto | | 100.0% | | | | | | | | |
| Margen Operativo | | -13586.0% | | | | | | | | |
| Margen EBITDA | | -13586.0% | | | | | | | | |
| Margen Neto | | -13586.0% | | | | | | | | |
| Margen FCF | | -30079.7% | | | | | | | | |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.27 | $-61.44 | $-182.02 | $-129.02 | $-103.25 | $-39.52 | $-48.16 | $-17.78 | $-6.05 | $-2.55 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $101000 | $101000 | $90848 | $108557 | $185291 | $537618 | $595882 | $609056 | $1.1M | $3.3M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Salud financiera
| Piotroski F-Score | 1 |
| Altman Z-Score | -26.98 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -3874.45 | -40.49 | -15.23 | -0.98 | -0.59 | -1.01 | -1.29 | -2.03 | -0.29 | -0.90 |
| P/VC | -2090.03 | 11.50 | 6.78 | 1.06 | 0.52 | 0.66 | 1.00 | 2.75 | 0.36 | 3.47 |
| P/V | 0.00 | 5500.85 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 100.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | -13586.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | -13586.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |